Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer Screening Considerations: Balancing the Benefits and Risks

Metastatic Migration in Cancer may be Influenced by Metabolism

Pediatric Cancer

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Glossary

CDK9 and Cancer

What Causes Cancer?

Cancer Research

Cutaneous Manifestations of Internal Malignancy

Cancer Management

See more featured articles »

What is Tumorigenesis?

Targeted Cancer Therapies

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cancer Pathophysiology

Cancer Symptoms

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Cancer History

What is Merkel Cell Carcinoma?

TARDIS: The Improved Method of Detecting Breast Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer Classification

Cancer Pain Management

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Using Biomarkers to Detect Cancer

What is the Tumor Microenvironment?

Assay for Monitoring and Treating Malignant Brain Tumors

Acidosis and Tumor Progression

Effects of Social and Economic Deprivation on Cancer Mortality

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Hypoxia Markers and Their Importance

Insight into Cancer Vaccines

Cancer Epidemiology

What Role do Biobanks Play in Cancer Research?

What is Cancer?

Microfluidic cancer treatment screen combined with flow cytometry

Investigating the Molecular Mechanisms of Cancer

Is Cancer a Metabolic Disorder?

Myc Mutations and Cancer

Cancer Prognosis

What is Immunochemotherapy?

The Cancer Cell Surface Proteome as a Therapeutic Target

Overview of Cell Viability and Cytotoxicity

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Caring for a Loved One with Cancer

Hot vs Cold: the differences between tumor types

Cancer Prevention: Lowering your Risk

Living with Cancer Pain

British Pioneers in Cancer Biology

Cancer Diagnosis

Extracellular Vesicles as Floating Cancer Biomarkers

Transforming Cancer Care through Genomic Testing

Secondary Brain Cancer

Insights into Oncofertility

Why are Cancer Cell Lines Useful?

The Biochemistry of Breast Cancer Screening

Cancer Pain

Secondary Lung Cancer

What is Cancer of Unknown Primary?

The Effects of Cancer on Family Life

Latest Cancer News and Research

Invisible no more: New treatment avenue unlocked for deadliest lung cancer

Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally.

16 Oct 2026

invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal

invIOs GmbH (“invIOs”), a privately held biotechnology company developing innovative cancer immunotherapies, today announced the publication of new clinical data with its autologous PBMC (peripheral blood mononuclear cell) therapy APN401 in the peer-reviewed journal, Molecular Therapy Oncology.

16 Oct 2026

Bisphenol mixtures alter breast tissue development in lab-grown human models

Exposure to common chemicals may alter how normal human breast tissue develops, according to a new study from researchers at Tufts University School of Medicine and Boston University

15 Oct 2026

New study could help reduce radiation exposure during cardiac CT scans

A new study at The University of Texas at Arlington could help substantially reduce the amount of radiation heart patients receive during imaging procedures without sacrificing diagnostic accuracy.

15 Oct 2026

AI study of 101,000 patients links brown fat to heart and mental health

In a retrospective analysis of PET-CT records from 101,243 patients, researchers found that detectable brown fat was associated with lower prevalence of cardiometabolic and psychiatric conditions, while greater activity, particularly in the axillary region, was linked to more favourable metabolic outcomes. Medication screening identified losartan, which increased brown fat thermogenic activity in laboratory experiments and energy expenditure in mice, although its effects on human brown fat remain unproven.

15 Oct 2026

New paper urges adoption of green AI in healthcare

AI is already widely used in hospitals and medical research. Can a new way of thinking unleash the technology’s green credentials?

15 Oct 2026

New trial aims to test whether a blood test can detect breast cancer earlier than mammograms

Researchers at USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, have launched a clinical trial to evaluate whether a blood test can help detect breast cancer earlier than mammograms alone.

15 Oct 2026

Blood Cancer United awards grant to diversify clinical trial access

Blood Cancer United, formerly The Leukemia & Lymphoma Society, has awarded $2.5 million to a research team led by Melissa Beauchemin, Ph.D., Assistant Professor at Columbia University School of Nursing, through its Equity in Access Research Program.

15 Oct 2026

Lactation drug cabergoline may reduce breast cancer risk in mothers

An international team of scientists has found that a lactation drug could reduce the risk of breast cancer in mothers after childbirth.

15 Oct 2026

Light-activated experimental opioid eliminates dangerous side effects

Opioid painkillers are some of the strongest analgesic medicines, but they are also the riskiest owing to a range of side effects, including addiction.

15 Oct 2026

Targeting the STING pathway could help prevent osteoporosis

As we age, our bones become weak and brittle, a process called osteoporosis. This bone loss is caused by changes in the cells within the bone marrow microenvironment, such as elevated fat and inflammation-promoting immune cells.

15 Oct 2026

Coffee drinkers had fewer repeat blood clots in a Norwegian study

A Norwegian study involving 2,071 patients found that those who reported drinking 1 to 2 cups of coffee daily before their first venous thromboembolism had a 51% lower estimated risk of recurrence than non-drinkers. The association was strongest among patients whose initial blood clot was provoked, although the observational study could not establish that coffee consumption prevents recurrence.

14 Oct 2026

Experts call for lifelong care after brain and spinal injuries

In a new paper published in The Lancet Neurology, "Reframing traumatic brain injury and spinal cord injury as chronic multisystem disorders: toward integrated, long-term care," international experts across institutions and disciplines propose a fundamental shift in how traumatic brain and spinal cord injuries in adults are understood and managed. Sandro Marini, MD, of the Mass General Brigham Neuroscience Institute, is a co-first author, and Saef Izzy, MD, also of the Neuroscience Institute, is one of the co-senior authors, and the primary corresponding author.

14 Oct 2026

Recurrent brain tumors undergo unique genetic changes after treatment

When patients are diagnosed with certain brain tumors, one of the biggest unanswered questions is what happens when the cancer returns.

14 Oct 2026

WEHI study reveals a new immune pathway for fighting small cell lung cancer

Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally.

14 Oct 2026

New project receives $2.3 million to develop a database and AI model to identify therapeutic peptides

A group of scientists led by Joseph Brown, assistant professor at the Leslie Dan Faculty of Pharmacy, has received $2.3 million USD in funding to develop a database and AI training model to identify peptides with therapeutic potential.

14 Oct 2026

Sex hormones dictate how skin stem cells renew themselves

For a long time, differences between females and males were mainly associated with the reproductive organs. Yet organs that have nothing to do with reproduction, such as the skin, can also be shaped by sex.

14 Oct 2026

Novel gene rejuvenation therapy preserves cell identity while reversing age

Every organ and tissue progressively loses function and integrity as it ages. In fact, researchers have identified "hallmarks of aging" that not only present specific processes impacted by age, but are also thought of as levers that, if successfully targeted, could help turn back the aging clock and result in tissue rejuvenation.

14 Oct 2026

Common blood pressure drug boosts brown adipose tissue activity and metabolism

Scientists have discovered that the drug losartan, commonly prescribed for high blood pressure, boosts brown adipose tissue activity in mice, enhancing their metabolism.

14 Oct 2026

New study highlights severe depression risks for young doctor trainees

Every summer, more than 1,600 recent medical school graduates start training to become obstetrician-gynecologists at hospitals across the United States.

14 Oct 2026